ATLANTA, GA – Georgia Tech has been chosen by the National Institutes of Health (NIH), a U.S. government agency that provides leadership and financial support to medical researchers, to house a $10 million nanomedicine laboratory.

Nanomedicine is the study of medicine at a molecular level, and covers areas such as nanoparticle drug delivery and possible viable applications of nanotechnology and nanovaccinology.

The latest NIH grant puts Georgia Tech in select company; so select, in fact, that it’s completely unique in the nation. Tech already has received funding for an $11.5 million nanocardiology lab and a $19 million nanocancer center.

Now, Georgia Tech will have the only program in the nation with three nanomedicine centers. However, although the lab will be located at Georgia Tech, it will be jointly operated by Emory University and the Medical College of Georgia.

Discoveries in the new center could lead to breakthroughs in fighting cancer or reversing the harmful effects of genetic disorders, said Jeff Schloss, co-chair of the NIH Nanomedicine Roadmap Initiative.

The Roadmap Inititiaive is dedicated to attainging a better understanding of the innerworkings of human cells, and it was the program through which the various universities competed for the grants.

Georgia Tech is one of just eight schools in the nation to receive the NIH awards. The grant shows the increasing emphasis of nanomedicine in medical research, and could spell more economic development in the biosciences industry in Atlanta.

Southeast Venture Conference, February 29 – March 1, 2012 at the Ritz Carlton in Tysons Corner, VA – Where Smart Money Meets Smart People.
www.seventure.org

© 2006, TechJournal South. All rights reserved.